TY - JOUR
T1 - Mutation analyses by next-generation sequencing and multiplex ligation-dependent probe amplification in Japanese autosomal dominant polycystic kidney disease patients
AU - Mochizuki, Toshio
AU - Teraoka, Atsuko
AU - Akagawa, Hiroyuki
AU - Makabe, Shiho
AU - Akihisa, Taro
AU - Sato, Masayo
AU - Kataoka, Hiroshi
AU - Mitobe, Michihiro
AU - Furukawa, Toru
AU - Tsuchiya, Ken
AU - Nitta, Kosaku
N1 - Funding Information:
We express our sincere appreciation to all the patients, collaborating physicians, and other medical staff for their important contributions to the study. This study was supported in part by JSPS KAKENHI Grant Number JP 15K09279 and by a Grant-in-Aid for Intractable Renal Diseases Research, Research on rare and intractable diseases, Health and Labour Sciences Research Grants from the Ministry of Health, Labour and Welfare of Japan.
Publisher Copyright:
© 2019, Japanese Society of Nephrology.
PY - 2019/8/1
Y1 - 2019/8/1
N2 - Background: Autosomal dominant polycystic kidney disease (ADPKD), one of the most common hereditary kidney diseases, causes gradual growth of cysts in the kidneys, leading to renal failure. Owing to the advanced technology of next-generation sequencing (NGS), genetic analyses of the causative genes PKD1 and PKD2 have been improved. Methods: We performed genetic analyses of 111 Japanese ADPKD patients using hybridization-based NGS and long-range (LR)-PCR-based NGS. Additionally, genetic analyses in exon 1 of PKD1 using Sanger sequencing because of an extremely low coverage of NGS and those using multiplex ligation-dependent probe amplification (MLPA) were performed. Results: The detection rate using NGS for 111 patients was 86.5%. One mutation in exon 1 of PKD1 and five deletions detected by MLPA were identified. When combined, the total detection rate was 91.9%. Conclusion: Although NGS is useful, we propose the addition of Sanger sequencing for exon 1 of PKD1 and MLPA as indispensable for identifying mutations not detected by NGS.
AB - Background: Autosomal dominant polycystic kidney disease (ADPKD), one of the most common hereditary kidney diseases, causes gradual growth of cysts in the kidneys, leading to renal failure. Owing to the advanced technology of next-generation sequencing (NGS), genetic analyses of the causative genes PKD1 and PKD2 have been improved. Methods: We performed genetic analyses of 111 Japanese ADPKD patients using hybridization-based NGS and long-range (LR)-PCR-based NGS. Additionally, genetic analyses in exon 1 of PKD1 using Sanger sequencing because of an extremely low coverage of NGS and those using multiplex ligation-dependent probe amplification (MLPA) were performed. Results: The detection rate using NGS for 111 patients was 86.5%. One mutation in exon 1 of PKD1 and five deletions detected by MLPA were identified. When combined, the total detection rate was 91.9%. Conclusion: Although NGS is useful, we propose the addition of Sanger sequencing for exon 1 of PKD1 and MLPA as indispensable for identifying mutations not detected by NGS.
KW - ADPKD
KW - MLPA
KW - Next-generation sequencing
KW - PKD1
KW - PKD2
KW - Polycystic kidney disease
UR - http://www.scopus.com/inward/record.url?scp=85064466406&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85064466406&partnerID=8YFLogxK
U2 - 10.1007/s10157-019-01736-3
DO - 10.1007/s10157-019-01736-3
M3 - Article
C2 - 30989420
AN - SCOPUS:85064466406
SN - 1342-1751
VL - 23
SP - 1022
EP - 1030
JO - Clinical and Experimental Nephrology
JF - Clinical and Experimental Nephrology
IS - 8
ER -